NVOS logo

Novo Integrated Sciences (NVOS) EBITDA

Annual EBITDA

-$5.85 M
+$16.63 M+73.98%

August 31, 2023

Summary

Performance

1-Year Change

+73.98%

3-Year Change

-76.04%

5-Year Change

-295.39%

15-Year Change

-52593.69%

NVOS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

71.93%
NVOS annual EBITDA is higher than 71.93% of companies in Healthcare sector

High & Low

All-time High

-$11.10 K

3-Year Low

-$22.48 M

Earnings dates

Last Annual Earnings Report Date

Aug 31, 2023
NVOS previous annual earnings announcement was published on Aug 31, 2023

Next Annual Earnings Report Date

N/A
NVOS next annual earnings announcement has not yet been scheduled

OtherNVOSprofitabilitymetrics:

Annual Revenue

$12.57 M
NVOS annual revenue is $12.57 million

Annual Net Income

-$13.21 M
NVOS annual net profit is -$13.21 million

Annual EBIT

-$8.15 M
NVOS annual earnings before interest & taxes is -$8.15 million

Annual EPS

-$1.30
NVOS annual earnings per share is -$1.30

Quarterly EBITDA

-$10.10 M
-$9.17 M-992.55%

May 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-1264.18%

3-Year Change

-496.43%

5-Year Change

-496.43%

NVOS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.77%
NVOS quarterly EBITDA is higher than 35.77% of companies in Healthcare sector

High & Low

All-time High

$188.20 K
NVOS quarterly EBITDA is currently -5464.67% below its historical high of $188.20 thousand

3-Year Low

-$19.86 M

Earnings dates

Last Quarterly Earnings Report Date

May 31, 2024
NVOS previous earnings announcement was published on May 31, 2024

Next Quarterly Earnings Report Date

N/A
NVOS next earnings announcement has not yet been scheduled

OtherNVOSprofitabilitymetrics:

Quarterly Revenue

$3.15 M
NVOS quarterly revenue is $3.15 million

Quarterly Net Income

-$13.74 M
NVOS quarterly net profit is -$13.74 million

Quarterly EBIT

-$10.65 M
NVOS quarterly earnings before interest & taxes is -$10.65 million

Quarterly EPS

-$0.74
NVOS quarterly earnings per share is -$0.74

TTM EBITDA

-$16.02 M
-$9.36 M-140.47%

May 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+31.92%

3-Year Change

+30.89%

5-Year Change

+30.89%

NVOS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

54.49%
NVOS TTM EBITDA is higher than 54.49% of companies in Healthcare sector

High & Low

All-time High

$74.70 K
NVOS TTM EBITDA is currently <-9900.00% below its historical high of $74.70 thousand

3-Year Low

-$23.53 M

Earnings dates

Last Quarterly Earnings Report Date

May 31, 2024
NVOS previous earnings announcement was published on May 31, 2024

Next Quarterly Earnings Report Date

N/A
NVOS next earnings announcement has not yet been scheduled

OtherNVOSprofitabilitymetrics:

TTM Revenue

$13.52 M
NVOS TTM revenue is $13.52 million

TTM Net Income

-$24.33 M
NVOS TTM net profit is -$24.33 million

TTM EBIT

-$18.30 M
NVOS TTM earnings before interest & taxes is -$18.30 million

TTM EPS

-$1.31
NVOS TTM earnings per share is -$1.31

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$5.85 M
NVOS annual EBITDA is -$5.85 million

Annual Net Income

-$13.21 M
NVOS annual net profit is -$13.21 million

Annual Interest Expense

$5.12 M
NVOS annual interest expense is $5.12 million

Annual Income Tax

$0.00
NVOS annual income tax is $0.00

Annual D&A

$2.30 M
NVOS annual depreciation & amortization is $2.30 million

NVOS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+74.0%-1264.2%+31.9%
3 y3 years-76.0%-496.4%+30.9%
5 y5 years-295.4%-496.4%+30.9%

NVOS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-126.5%+74.0%-4593.8%+49.2%-402.7%+31.9%
5 y5-year-6838.3%+74.0%<-9999.0%+49.2%<-9999.0%+31.9%
alltimeall time<-9999.0%+74.0%-5464.7%+49.2%<-9999.0%+31.9%

Novo Integrated Sciences EBITDA History

DateAnnualQuarterlyTTM
May 2024
-
-$10.10 M(+992.6%)
-$16.02 M(+140.5%)
Feb 2024
-
-$924.10 K(-67.8%)
-$6.66 M(-4.4%)
Nov 2023
-
-$2.87 M(+34.8%)
-$6.96 M(+20.3%)
Aug 2023
-$5.85 M(-74.0%)
-$2.13 M(+187.5%)
-$5.79 M(-75.4%)
May 2023
-
-$740.10 K(-39.7%)
-$23.53 M(+2.3%)
Feb 2023
-
-$1.23 M(-27.4%)
-$23.00 M(-0.8%)
Nov 2022
-
-$1.69 M(-91.5%)
-$23.18 M(+3.1%)
Aug 2022
-$22.48 M(+770.7%)
-$19.86 M(+9134.7%)
-$22.48 M(+482.9%)
May 2022
-
-$215.10 K(-84.7%)
-$3.86 M(+5.6%)
Feb 2022
-
-$1.41 M(+41.2%)
-$3.65 M(+14.7%)
Nov 2021
-
-$995.50 K(-19.7%)
-$3.19 M(+23.4%)
Aug 2021
-$2.58 M(-22.3%)
-$1.24 M(>+9900.0%)
-$2.58 M(-37.8%)
May 2021
-
-$12.10 K(-98.7%)
-$4.15 M(-0.6%)
Feb 2021
-
-$938.10 K(+139.8%)
-$4.18 M(+13.3%)
Nov 2020
-
-$391.20 K(-86.1%)
-$3.69 M(+10.9%)
Aug 2020
-$3.32 M(+3841.3%)
-$2.81 M(+7080.6%)
-$3.32 M(+917.0%)
May 2020
-
-$39.10 K(-91.3%)
-$326.70 K(+1.5%)
Feb 2020
-
-$447.10 K(+1457.8%)
-$321.90 K(-530.9%)
Nov 2019
-
-$28.70 K(-115.2%)
$74.70 K(-188.6%)
Aug 2019
-$84.30 K(-94.3%)
$188.20 K(-648.7%)
-$84.30 K(-74.3%)
May 2019
-
-$34.30 K(-32.1%)
-$328.40 K(-27.2%)
Feb 2019
-
-$50.50 K(-73.1%)
-$451.20 K(-70.1%)
Nov 2018
-
-$187.70 K(+235.8%)
-$1.51 M(+2.1%)
Aug 2018
-$1.48 M(>+9900.0%)
-$55.90 K(-64.4%)
-$1.48 M(+8.7%)
May 2018
-
-$157.10 K(-85.8%)
-$1.36 M(-6.5%)
Feb 2018
-
-$1.11 M(+605.0%)
-$1.46 M(+279.0%)
Nov 2017
-
-$157.30 K(-353.3%)
-$384.20 K(+42.6%)
Aug 2017
-$11.10 K(-93.3%)
$62.10 K(-124.6%)
-$269.40 K(-27.0%)
May 2017
-
-$252.00 K(+581.1%)
-$368.80 K(+175.6%)
Mar 2017
-
-$37.00 K(-12.9%)
-$133.80 K(-18.9%)
Dec 2016
-$164.90 K(-58.8%)
-$42.50 K(+13.9%)
-$164.90 K(+119.9%)
Sep 2016
-
-$37.30 K(+119.4%)
-$75.00 K(-11.8%)
Jun 2016
-
-$17.00 K(-75.0%)
-$85.00 K(-80.0%)
Mar 2016
-
-$68.10 K(-243.7%)
-$424.10 K(+5.8%)
Dec 2015
-$400.60 K(+21.5%)
$47.40 K(-200.2%)
-$400.70 K(-25.8%)
Sep 2015
-
-$47.30 K(-86.7%)
-$540.00 K(-3.9%)
Jun 2015
-
-$356.10 K(+696.6%)
-$562.20 K(+45.3%)
Mar 2015
-
-$44.70 K(-51.4%)
-$387.00 K(-0.5%)
Dec 2014
-$329.80 K
-$91.90 K(+32.2%)
-$389.10 K(+53.8%)
DateAnnualQuarterlyTTM
Sep 2014
-
-$69.50 K(-61.6%)
-$253.00 K(+0.1%)
Jun 2014
-
-$180.90 K(+286.5%)
-$252.70 K(-18.5%)
Mar 2014
-
-$46.80 K(-205.9%)
-$310.10 K(-30.0%)
Dec 2013
-$443.20 K(-55.2%)
$44.20 K(-163.9%)
-$443.00 K(-24.7%)
Sep 2013
-
-$69.20 K(-71.0%)
-$588.60 K(-11.7%)
Jun 2013
-
-$238.30 K(+32.6%)
-$666.60 K(-13.8%)
Mar 2013
-
-$179.70 K(+77.2%)
-$773.70 K(-21.7%)
Dec 2012
-$989.90 K(-55.4%)
-$101.40 K(-31.1%)
-$987.80 K(-23.7%)
Sep 2012
-
-$147.20 K(-57.4%)
-$1.29 M(-21.5%)
Jun 2012
-
-$345.40 K(-12.3%)
-$1.65 M(-7.5%)
Mar 2012
-
-$393.80 K(-3.4%)
-$1.78 M(-19.7%)
Dec 2011
-$2.22 M(-4.6%)
-$407.70 K(-18.6%)
-$2.22 M(-0.7%)
Sep 2011
-
-$501.10 K(+4.5%)
-$2.23 M(+23.2%)
Jun 2011
-
-$479.70 K(-42.2%)
-$1.81 M(-27.5%)
Mar 2011
-
-$830.10 K(+96.5%)
-$2.50 M(+7.6%)
Dec 2010
-$2.32 M(+17.8%)
-$422.40 K(+426.7%)
-$2.32 M(-13.4%)
Sep 2010
-
-$80.20 K(-93.1%)
-$2.69 M(-15.7%)
Jun 2010
-
-$1.17 M(+78.8%)
-$3.19 M(+36.3%)
Mar 2010
-
-$653.70 K(-16.5%)
-$2.34 M(+18.5%)
Dec 2009
-$1.97 M(+108.8%)
-$783.30 K(+34.7%)
-$1.97 M(+29.5%)
Sep 2009
-
-$581.70 K(+82.3%)
-$1.52 M(+26.3%)
Jun 2009
-
-$319.10 K(+10.2%)
-$1.21 M(+13.8%)
Mar 2009
-
-$289.50 K(-13.3%)
-$1.06 M(+12.3%)
Dec 2008
-$945.40 K(-61.8%)
-$334.10 K(+26.2%)
-$945.40 K(-35.4%)
Sep 2008
-
-$264.70 K(+53.0%)
-$1.46 M(-13.0%)
Jun 2008
-
-$173.00 K(-0.3%)
-$1.68 M(-14.7%)
Mar 2008
-
-$173.60 K(-79.6%)
-$1.97 M(-20.2%)
Dec 2007
-$2.47 M(+69.4%)
-$852.50 K(+76.5%)
-$2.47 M(+15.7%)
Sep 2007
-
-$482.90 K(+4.1%)
-$2.14 M(-3.5%)
Jun 2007
-
-$463.80 K(-31.2%)
-$2.22 M(+10.2%)
Mar 2007
-
-$674.40 K(+30.5%)
-$2.01 M(+37.6%)
Dec 2006
-$1.46 M(+36.9%)
-$516.80 K(-7.7%)
-$1.46 M(+19.6%)
Sep 2006
-
-$560.20 K(+116.5%)
-$1.22 M(+56.4%)
Jun 2006
-
-$258.80 K(+107.4%)
-$781.10 K(-18.2%)
Mar 2006
-
-$124.80 K(-55.1%)
-$955.20 K(-10.5%)
Dec 2005
-$1.07 M(+409.9%)
-$277.90 K(+132.4%)
-$1.07 M(+35.2%)
Sep 2005
-
-$119.60 K(-72.4%)
-$788.90 K(+17.9%)
Jun 2005
-
-$432.90 K(+83.1%)
-$669.30 K(+183.1%)
Mar 2005
-
-$236.40 K
-$236.40 K
Dec 2004
-$209.20 K
-
-

FAQ

  • What is Novo Integrated Sciences annual EBITDA?
  • What is the all time high annual EBITDA for Novo Integrated Sciences?
  • What is Novo Integrated Sciences annual EBITDA year-on-year change?
  • What is Novo Integrated Sciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Novo Integrated Sciences?
  • What is Novo Integrated Sciences quarterly EBITDA year-on-year change?
  • What is Novo Integrated Sciences TTM EBITDA?
  • What is the all time high TTM EBITDA for Novo Integrated Sciences?
  • What is Novo Integrated Sciences TTM EBITDA year-on-year change?

What is Novo Integrated Sciences annual EBITDA?

The current annual EBITDA of NVOS is -$5.85 M

What is the all time high annual EBITDA for Novo Integrated Sciences?

Novo Integrated Sciences all-time high annual EBITDA is -$11.10 K

What is Novo Integrated Sciences annual EBITDA year-on-year change?

Over the past year, NVOS annual EBITDA has changed by +$16.63 M (+73.98%)

What is Novo Integrated Sciences quarterly EBITDA?

The current quarterly EBITDA of NVOS is -$10.10 M

What is the all time high quarterly EBITDA for Novo Integrated Sciences?

Novo Integrated Sciences all-time high quarterly EBITDA is $188.20 K

What is Novo Integrated Sciences quarterly EBITDA year-on-year change?

Over the past year, NVOS quarterly EBITDA has changed by -$9.36 M (-1264.18%)

What is Novo Integrated Sciences TTM EBITDA?

The current TTM EBITDA of NVOS is -$16.02 M

What is the all time high TTM EBITDA for Novo Integrated Sciences?

Novo Integrated Sciences all-time high TTM EBITDA is $74.70 K

What is Novo Integrated Sciences TTM EBITDA year-on-year change?

Over the past year, NVOS TTM EBITDA has changed by +$7.51 M (+31.92%)